Back to Archive
November 13, 2025

🚀 Oracle, Intel Power Up | Eli Lilly's Health Breakthroughs

🎯 TL;DR

Today in stocks: Oracle is beefing up its AI and cloud game, Intel's staying strong in the chip world with AI and cloud focus, and Eli Lilly's looking good with its work on diabetes, cancer, and brain health. Big things happening!

📊 Today's Stocks at a Glance

🔹 ORCL

Technology

Track Record

What it does

Oracle Corporation is a leading technology company specializing in software and cloud computing solutions, with a current focus on expanding its reach in artificial intelligence and machine learning.

Why it matters today

Oracle's aggressive push into AI and cloud computing positions it as a key player in digital transformation, making it an important stock for technology investors.

Price

$226.99

Action

BUY

Stop Loss

Pro

Profit Target

Pro

Risk/Reward Ratio: 1:2.0

🧭What to Do: Hold steady with a view to buy on dips, given Oracle's solid fundamentals and strategic focus on AI and cloud markets.

Why this matters to you

Despite recent price volatility, Oracle's stock remains within a strong uptrend, supported by bullish news sentiment and significant cloud growth.

Risk level: MediumConfidence:Pro

🔹 INTC

Technology

Track Record

What it does

Intel Corporation is a leading name in the global semiconductor industry, focusing on innovations in AI and cloud solutions to maintain its market dominance amidst shifting industry demands.

Why it matters today

Intel's strategic pivot towards data-centric technologies and AI positions it to capitalize on the growing demand for advanced computing capabilities.

Price

$37.89

Action

BUY

Stop Loss

Pro

Profit Target

Pro

Risk/Reward Ratio: 1:2.3

🧭What to Do: Hold steady for current investors, potential buy for new investors looking for a long-term play in semiconductors.

Why this matters to you

The stock has shown modest price improvements with a current uptrend from its 52-week low, suggesting potential for growth.

Risk level: MediumConfidence:Pro

🔹 LLY

Healthcare

Track Record

What it does

Eli Lilly is a global pharmaceutical leader with a focus on diabetes, oncology, and neurodegenerative disorders. With its high market cap and bullish news sentiment, LLY shows strong growth potential.

Why it matters today

LLY's innovative healthcare solutions and strategic partnerships position it well for substantial growth, making it a significant stock in the healthcare sector.

Price

$1017.78

Action

BUY

Stop Loss

Pro

Profit Target

Pro

Risk/Reward Ratio: 1:2.0

🧭What to Do: Potential buy

Why this matters to you

With a recent price surge to a 52-week high, LLY demonstrates strong momentum amid positive news coverage.

Risk level: MediumConfidence:Pro

Pro Features

Unlock Full Analysis

Free readers see a limited version of this brief. Pro members unlock confidence scores, stop-loss levels, profit targets, and complete position sizing recommendations across the full archive.

Starting at $8/month60-day guarantee

Share this brief

Help others discover Daily Ticker

Get daily briefs

Receive market insights every morning at 8 AM EST